|
|
|
|
|
Teisinis statusas
Patento galiojimo terminas pasibaigęs
| (51) | INT.CL. | A61K | (2006.01) |
| A61K 31/415 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/5517 | (2006.01) | ||
| A61P | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| C07D | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Patento numeris | 1140941 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 99967444.3 |
| Europos patento paraiškos padavimo data | 1999-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2001-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2004-10-20 |
| (46) | Apibrėžties vertimo paskelbimo data | 2005-02-25 |
| (86) | Numeris | PCT/US1999/030316 |
| Data | 1999-12-17 |
| (87) | Numeris | WO 2000/039131 |
| Data | 2000-07-06 |
| (30) | Numeris | Data | Šalis |
| 113628 P | 1998-12-23 | US | |
| 127633 P | 1999-04-02 | US |
| (72) |
FEVIG, John, M., US
CACCIOLA, Joseph, US
CLARK, Charles, G., US
LAM, Patrick, Yuk, Sun, US
PINTO, Donald, J., P., US
PRUITT, James, R., US
ROSSI, Karen, A., US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Azotą turintys heterobiciklai kaip XA faktoriaus inhibitoriai |
| NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2018-11-26 | 20 | 347.00 EUR |